LoginRegister

    Pfizer Q2 net profit falls 14% to Rs 95.8 crore

    Medical Dialogues BureauWritten by Medical Dialogues Bureau   |  
    New Delhi: Drug firm Pfizer has recently reported a 13.81 per cent dip in standalone net profit to Rs 95.8 crore for the quarter ended September 2018.

    The company had posted a net profit of Rs 111.15 crore for the corresponding period of the previous fiscal.

    Revenue from operations of the company stood at Rs 519.74 crore in the quarter under review. It was Rs 571.11 crore in the September quarter a year ago, Pfizer said in a filing to BSE.

    Read Also: Pfizer loses blockbuster Epilepsy drug patent fight in UK Supreme Court
    falls 14%PfizerQ2 net profitRs 95.8 crore
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X